Fred Alger Management »

Cidara Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $48M 503k 95.76

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
AppLovin Corp. Class A Equity (APP)
Nebius Group N.V. Class A Equity (NBIS)
Apple Equity (AAPL)
Broadcom Equity (AVGO)
Alphabet Inc. Class C Equity (GOOG)
Talen Energy Corp Equity (TLN)
Tesla Equity (TSLA)
Sea Limited Sponsored ADR Class A Equity (SE)
Netflix Equity (NFLX)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics